Fate Therapeutics, Inc. · NASDAQ:FATE
Goldman Sachs Group Inc's stake in Fate Therapeutics, Inc. fell to 2.00% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Goldman Sachs Group Inc's stake in Fate Therapeutics, Inc. fell to 2.00%, 2,274,020 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 2.00%
- Shares
- 2,274,020
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 2.00% | 2,274,020 |
| GOLDMAN SACHS & CO. LLC | 2.00% | 2,274,020 |
Source
Related
- Fate Therapeutics, Inc.
- Goldman Sachs Group Inc
- Fate Therapeutics, Inc. shareholders
- Schedule 13G · Goldman Sachs Group Inc · May 9, 2025
- Form 4 · Tahl Cindy · Aug 5, 2026
- Form 4 · Valamehr Bahram · Aug 5, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 8, 2026
- Form 4 · Tahl Cindy · May 21, 2026
- Form 4 · Valamehr Bahram · May 21, 2026